Cite

HARVARD Citation

    Gaule, M. et al. (2022). Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion. JCO precision oncology. p. . [Online]. 
  
Back to record